Navigation Links
Innocoll Submits SPA for Cogenzia(TM) Phase III Clinical Trials for the Adjuvant Treatment of Diabetic Foot Infections
Date:7/13/2010

antibiotics, a milestone event for the treatment of this large and rapidly growing unmet medical need."  

Diabetic Foot Ulcers Infections:

Diabetic foot ulcer (DFU) infections represent a large and growing market for Cogenzia.  According to the American Diabetes Association there were 23.6 million diabetic patients in the U.S. in 2007 and 220 million patients globally.  Of these patients, approximately 15% will develop a DFU and 50% of those patients will develop an infected DFU, representing an estimated 2 million patients.   Infected DFUs are currently treated with systemic antibiotics.  However, diabetic ulcers are often associated with limited perfusion due to vascular disease and ischemia thereby rendering systemically acting antibiotics ineffective. According to a meta-analysis of 18 randomized controlled trials evaluating different antibiotics in treatment of diabetic foot infections, the combined observed treatment failure rate of antibiotic treatments of DFU infections is 22.7%. Local antibiotic treatment adjunct to a systemic agent can potentially address the unmet need in infections in DFU by improving anti-bacterial efficacy at the wound site.  There are currently no approved, topically applied antibiotics in the U.S. that are indicated for the treatment of infections in DFU.  

About Cogenzia:  

Cogenzia is a biodegradable and fully resorbable Gentamicin-Collagen Sponge formulated and manufactured using Innocoll's proprietary collagen-based drug delivery technology, CollaRx. Upon application to an open wound the product releases gentamicin, a broad-spectrum, aminoglycoside antibiotic with a concentration-dependent mechanism of action, for local action at the wound site. This technology achieves a high concentration of drug at the target tissue, while maintaining low systemic
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients
2. Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients
3. Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
5. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
6. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
10. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
11. Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...  Encision Inc. (OTCQB:ECIA), a medical device company owning ... in minimally invasive surgery, today announced financial results for ... The Company posted quarterly net revenue of ... thousand, or $(0.02) per share. These results compare to ... of $311 thousand, or $(0.04) per share, in the ...
(Date:7/29/2014)... Health 2.0 announces Bernard Tyson , CEO of ... Topol , Patrick Soon-Shiong , and Samsung,s President ... Fall Conference this coming Sept. 21-24 in ... set to host the very first Wearable Tech Fashion Runway ... Tech & Wearables: Powering Healthy Lifestyles. The panel will ...
(Date:7/29/2014)... July 29, 2014   ... study investigating the efficacy and safety of MSB0010718C in patients ... a rare and aggressive skin cancer lacking effective treatments   ... cohort Phase I clinical trial for the treatment of solid ... EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Satellite Dialysis Opens New Center in Merced, CA 2Satellite Dialysis Opens New Center in Merced, CA 3Satellite Dialysis Opens New Center in Merced, CA 4PDI Reports 2009 Fourth Quarter and Full Year Financial Results 2PDI Reports 2009 Fourth Quarter and Full Year Financial Results 3PDI Reports 2009 Fourth Quarter and Full Year Financial Results 4PDI Reports 2009 Fourth Quarter and Full Year Financial Results 5PDI Reports 2009 Fourth Quarter and Full Year Financial Results 6PDI Reports 2009 Fourth Quarter and Full Year Financial Results 7PDI Reports 2009 Fourth Quarter and Full Year Financial Results 8PDI Reports 2009 Fourth Quarter and Full Year Financial Results 9PDI Reports 2009 Fourth Quarter and Full Year Financial Results 10PDI Reports 2009 Fourth Quarter and Full Year Financial Results 11PDI Reports 2009 Fourth Quarter and Full Year Financial Results 12PDI Reports 2009 Fourth Quarter and Full Year Financial Results 13PDI Reports 2009 Fourth Quarter and Full Year Financial Results 14PDI Reports 2009 Fourth Quarter and Full Year Financial Results 15PDI Reports 2009 Fourth Quarter and Full Year Financial Results 16PDI Reports 2009 Fourth Quarter and Full Year Financial Results 17PDI Reports 2009 Fourth Quarter and Full Year Financial Results 18PDI Reports 2009 Fourth Quarter and Full Year Financial Results 19PDI Reports 2009 Fourth Quarter and Full Year Financial Results 20PDI Reports 2009 Fourth Quarter and Full Year Financial Results 21PDI Reports 2009 Fourth Quarter and Full Year Financial Results 22PDI Reports 2009 Fourth Quarter and Full Year Financial Results 23PDI Reports 2009 Fourth Quarter and Full Year Financial Results 24PDI Reports 2009 Fourth Quarter and Full Year Financial Results 25PDI Reports 2009 Fourth Quarter and Full Year Financial Results 26PDI Reports 2009 Fourth Quarter and Full Year Financial Results 27PDI Reports 2009 Fourth Quarter and Full Year Financial Results 28PDI Reports 2009 Fourth Quarter and Full Year Financial Results 29PDI Reports 2009 Fourth Quarter and Full Year Financial Results 30PDI Reports 2009 Fourth Quarter and Full Year Financial Results 31PDI Reports 2009 Fourth Quarter and Full Year Financial Results 32PDI Reports 2009 Fourth Quarter and Full Year Financial Results 33
(Date:7/29/2014)... 29, 2014 Award-winning inventor Michael Croix has ... neutralizer specifically designed to absorb embarrassing odors in the office. ... easily be stored in a desk drawer. This compact packaging ... users will simply sit on the pad and poof away! ... office and then BAM, someone appears out of nowhere. It’s ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Riverdale Urgent ... what they do. Through their presence at local events, ... to be more than just a medical service for ... Care donated money in support of Riverdale RiverFest and ... community event that features local musicians and entertainers, arts ...
(Date:7/29/2014)... Lean and Lovely, an affordable and short program, claims ... wear a bikini in the near future. This has caught ... , “Our Lean and Lovely review shows that ... levels. Neither your age nor your body shape matters, which ... the beginning, you will achieve the results that you have ...
(Date:7/29/2014)... AZ (PRWEB) July 29, 2014 Current ... was prescribed pain medication post foot surgery during his first ... time in foot surgery – twice on one foot, once ... prescription drugs. “I broke my foot a year ago and ... was recommended to Jon by a friend from home who’d ...
(Date:7/29/2014)... PeopleKeys today announced that they are launching a ... train and certify others in applied DISC behavioral analysis. ... will be taught by PeopleKeys Master Coach Dan Mucci ... a live Tele-course over the span of 10 weeks ... Trainer course will use a combination of real-time online ...
Breaking Medicine News(10 mins):Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 2Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 3Health News:Riverdale Urgent Care of the Bronx, NY Puts a Face Back on Medicine 2Health News:Riverdale Urgent Care of the Bronx, NY Puts a Face Back on Medicine 3Health News:Lean and Lovely: Review Examining Neghar Fonooni’s Program Released 2Health News:Back2Basics Sober Living Resident Overcomes Obstacle in Early Sobriety 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 3
... Nile Therapeutics, Inc., (Nasdaq: NLTX ), announced today ... 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, ... The Westin St. Francis Hotel in San Francisco, CA. ... clinical development programs for its lead compound, CD-NP, a novel ...
... Antonio Villaraigosa, Cal State LA President James Rosser, ... for the construction dedication ceremony of its new ... SA (Grifols), a global healthcare company based in ... Villaraigosa., Cal State LA President James Rosser, Councilman ...
... 50 labor organizations, including United Healthcare Workers and the ... to overturn ban on same-sex marriageOAKLAND, Calif., Jan. 13 ... organizations, including United Healthcare Workers (UHW) and the California ... support of the three lawsuits now challenging Proposition 8, ...
... prescribing of cholesterol-lowering drugs, experts say , , ... start taking results of a recent drug company-sponsored ... be taking cholesterol-lowering statin medications, experts say. , ... in November 2008. The study was cut short, ...
... Tricyclic medications helped with pain, fatigue and depression, ... -- Antidepressants may help people living with the ... improve their quality of life, new research shows. ... of Klinikum Saarbrucken in Germany, found that fibromyalgia ...
... Then warm up - and protect yourself from the dangers ... temperatures are hitting most of the country this week, but ... long winter months. If you do go outside for some ... yourself from frostbite . When body tissues are frostbitten, ...
Cached Medicine News:Health News:Nile Therapeutics to Present at the 27th Annual J.P. Morgan Healthcare Conference 2Health News:Grifols Celebrates Initial Construction of New IVIG Facility with Los Angeles Officials and Dignitaries 2Health News:Calif. Labor Unions Unite to Fight Prop 8 2Health News:Millions More Americans Might Be Placed on Statins 2Health News:Millions More Americans Might Be Placed on Statins 3Health News:Is Jack Frost Nipping At Your Nose? 2Health News:Is Jack Frost Nipping At Your Nose? 3
6.5mm diameter handpiece; 75mm handle with grooves for grip; Standard male luer taper fits most cannula hub and female luer taper....
Hook Shaped Tip , Curved to the Left; with 30 cm long silicone tubing with connector; overall length 40mm; stainless steel...
... forceps are designed for endomyocardial biopsies. ... a 3-pull ring handle, stainless steel cutting jaws, ... rotates to accommodate any position. ,A spring in ... jaws are opened by moving the double rings ...
The only solution for in-line digital measurement...
Medicine Products: